Ameritas Investment Partners’s Seres Therapeutics MCRB Stock Holding History

Ameritas Investment Partners’s Portfolio MCRB Stock Details MCRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-402	Closed	-$6.22K	–	3191
2024 Q1	$6.22K	Hold	402	–	–	﹤0.01%	2918
2023 Q4	$11.2K	Hold	402	–	–	﹤0.01%	2811
2023 Q3	$19.1K	Hold	402	–	–	﹤0.01%	2558
2023 Q2	$38.5K	Buy	402 +129	+47%	+$14K	﹤0.01%	2202
2023 Q1	$30.9K	Hold	273	–	–	﹤0.01%	2245
2022 Q4	$28.9K	Hold	273	–	–	﹤0.01%	2382
2022 Q3	$35K	Hold	273	–	–	﹤0.01%	2223
2022 Q2	$18K	Hold	273	–	–	﹤0.01%	2601
2022 Q1	$39K	Hold	273	–	–	﹤0.01%	2207
2021 Q4	$45K	Hold	273	–	–	﹤0.01%	2190
2021 Q3	$38K	Hold	273	–	–	﹤0.01%	2340
2021 Q2	$130K	Buy	273 +47	+21%	+$19.8K	﹤0.01%	1564
2021 Q1	$93K	Hold	226	–	–	﹤0.01%	1721
2020 Q4	$111K	Hold	226	–	–	0.01%	1517
2020 Q3	$128K	Buy	226 +66	+41%	+$21.9K	0.01%	1287
2020 Q2	$15K	Hold	160	–	–	﹤0.01%	2507
2020 Q1	$11K	Hold	160	–	–	﹤0.01%	2499
2019 Q4	$11K	Buy	160 +91	+132%	+$6.75K	﹤0.01%	2694
2019 Q3	$6K	Hold	69	–	–	﹤0.01%	2897
2019 Q2	$4K	Hold	69	–	–	﹤0.01%	2965
2019 Q1	$10K	Hold	69	–	–	﹤0.01%	2697
2018 Q4	$6K	Hold	69	–	–	﹤0.01%	2823
2018 Q3	$11K	Hold	69	–	–	﹤0.01%	2801
2018 Q2	$12K	Hold	69	–	–	﹤0.01%	2782
2018 Q1	$10K	Hold	69	–	–	﹤0.01%	2728
2017 Q4	$14K	Hold	69	–	–	﹤0.01%	2618
2017 Q3	$19K	Hold	69	–	–	﹤0.01%	2452
2017 Q2	$16K	Hold	69	–	–	﹤0.01%	2594
2017 Q1	$16K	Buy	+69	New	+$14K	﹤0.01%	2520

Other funds holding MCRB

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ameritas Investment Partners's MCRB Position: Q2 2024 in Review

Ameritas Investment Partners sold out of Seres Therapeutics (MCRB) in Q2 2024, closing a stake of 402 shares — an estimated $6.22K sold.

Ameritas Investment Partners first reported a position in MCRB in Q1 2017 and held it in 29 quarters. The position peaked at $130K in Q2 2021. 93 funds tracked by Wall St. Rank hold MCRB as of Q2 2024.

Ameritas Investment Partners reported no remaining Seres Therapeutics position as of Q2 2024 after selling out during the quarter.
Ameritas Investment Partners sold 402 Seres Therapeutics shares in Q2 2024, an estimated $6.22K.
Ameritas Investment Partners first reported a position in Seres Therapeutics in Q1 2017 and held it in 29 quarters.
Ameritas Investment Partners's Seres Therapeutics position peaked at $130K in Q2 2021.
93 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2024.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.